Match Document Document Title
D874652 Cover for cancer cell observation camera  
10551387 Cancer cell detection method using living body-derived cells  
A cancer cell detection method that makes it possible to perform imaging of cells in a living state and a dual detection method for cancer cells in which the aforementioned method is combined with...
10551385 Predicting cancer progression  
Method of determining a likelihood of cancer relapse in a subject who has completed cancer tumor surgery, radiotherapy treatment and/or chemotherapy treatment comprises contacting an antibody that...
10551383 Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancer  
The invention provides methods to identify, diagnose, and treat kidney cancer through the detection of expression and/or activity of anaplastic lymphoma kinase (ALK). The detection of the presence...
10550394 Anti-cancer RNA aptamers  
Provided herein, inter alia, are compounds capable of binding HSP70 (e.g. mHSP70) on a cell and internalizing into said cell. The compositions provided herein may be useful for delivering...
10550383 Galvanotaxis assay for quantitative assessment of the metastatic potential of cancer cells  
An apparatus and method for accelerating and/or inhibiting the migration of cells by applying a time-varying magnetic field to induce eddy currents that promote electrotaxis (galvanotaxis) of...
10550377 Suppression of prostate cancer using a targeted clostridial neurotoxin  
The present invention relates to a method for suppressing or treating cancer, in particular to a method for suppressing or treating one or more of colorectal cancer, breast cancer, prostate cancer...
10550191 Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8  
The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.
10550186 Cancer therapy targeting intercellular adhesion molecule 4 (ICAM4)  
Methods for treating cancer, e.g., in conjunction with anti-cancer therapy, like immunotherapy, and for identifying candidate therapeutic agents, by targeting ICAM4. While MDSCs in mice have been...
10550179 Compositions and methods for treating cancer with anti-mesothelin immunotherapy  
Chimeric antigen receptors containing mesothelin antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical...
10550167 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10550114 Kinase inhibitors and their use in cancer therapy  
The present invention relates to a 2,3-diphenyl-1,6-naphthyridine-5-one derivative according to general formula (I), and the use of the 2,3-diphenyl-1,6-naphthyridine-5-one derivative in the...
10549124 Multiple beamline position isocenterless positively charged particle cancer therapy apparatus and method of use thereof  
The invention comprises a method and apparatus for treating a tumor with protons using multiple beamline positions not having an isocenter, including the steps of: (1) delivering the protons from...
10549082 Methods for cancer treatment  
Residual, refractory or relapsed cancer is treated by immunostimulation in the presence of allogeneic immune effector cells, optimally in combination with radiation therapy. The methods of the...
10548950 Irisin-related cancer treatments  
In one embodiment, the invention provides methods of treating or preventing cancer, in particular aspects breast and/or prostate cancer, by administering to a subject in need thereof a...
10548861 Use of ureidomustine (BO-1055) in cancer treatment  
Method of using ureidomustine (BO-1055), a water-soluble NDA cross-linking agent, in the treatment of a cancer, selected from the group consisting of various types of human leukemia [such as acute...
10548842 Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer  
The present invention discloses c-MYC-siRNA formulation as a potential therapeutic target for cisplatin-resistant ovarian cancer. It is disclosed targeting c-MYC with small interfering RNA (siRNA)...
10548761 Method and system for reducing the likelihood of colorectal cancer in a human being  
A system and method for reducing the likelihood of colorectal cancer in a human being includes the modification of an individual's gut microbes by employing a Clustered Regularly Interspaced Short...
10545154 Method for the absolute quantification of naturally processed HLA-restricted cancer peptides  
The present invention relates to a method for the absolute quantification of naturally processed HLA-restricted cancer peptides, i.e. the determination of the copy number of peptide(s) as...
10545150 Lung cancer molecular markers  
The invention provides a method of diagnosis and/or prognosis of lung cancer, the method comprising the steps of: (a) determining the level of a C4 activation fragment in a test sample, and (b)...
10545136 Methods for the monitoring and prognosis of a cancer  
The present invention relates to methods for prognosis and monitoring of a cancer, preferably bladder cancer, by measuring the proportion of CD8+ T Lymphocytes expressing ILT-2 and the plasma...
10545133 Molecular signatures of invasive cancer subpopulations  
Carcinomas typically invade as a cohesive multicellular unit, a process termed collective invasion. It remains unclear how different subpopulations of cancer cells contribute to this process. We...
10544466 Method for diagnosing and treating cancer brain metastasis and drug delivery system for enabling passage through blood-brain barrier  
A method increases permeability of a blood-brain barrier in a subject. The method includes administering a small interfering ribonucleic acid (siRNA) against the 3-Phosphoinositide Dependent...
10544464 TERT promoter mutations in cancer  
The present invention relates to the field of cancer. More specifically, the present invention provides methods and compositions related to certain promoter mutations in cancer. In one embodiment,...
10544392 Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood  
Disclosed are methods of isolating T cells and TCRs having antigenic specificity for a mutated amino acid sequence encoded by a cancer-specific mutation. Also disclosed are related methods of...
10544224 Method of treating cancer using immune checkpoint inhibitor  
This disclosure provides a method for treating HPV-positive squamous cell carcinoma of the head and neck comprising administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1...
10544165 Method of treating cancer and other proliferative diseases with a gold(I) complex  
The invention is directed to a method of treatment of proliferative diseases or disorders such as cancer with gold(I) N-heterocyclic carbene (NHC) thiourea or substituted thiourea complexes, to...
10544125 Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts  
The present invention relates a new process to synthesize 1-((4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin -7-yloxy)methyl)cyclopropanamine (AL3818). A stable crystalline form of...
10544110 Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer  
A compound, or a pharmaceutically acceptable salt or ester thereof, according to formula I: R20—(Z)b—(Y)c—(R21)a—(X)d—R22—R23 wherein R20 is aryl, substituted aryl, heteroaryl, substituted...
10543346 Drug delivery systems and methods for treatment of bladder cancer  
Methods, devices, and medicaments that include oxaliplatin are provided for use in the treatment of bladder cancer by locally administering oxaliplatin into the bladder of a patient to achieve a...
10543279 Pyrrolobenzodiazepine conjugates and their use for the treatment of cancer  
A conjugate of formula (I): L-(DL)p, wherein L is a Ligand unit, D is a Drug Linker unit of formula (II), wherein p is an integer of from 1 to 20.
10543264 Cancer prevention and therapy by inhibiting soluble tumor necrosis factor  
Methods are disclosed for inhibiting the development of a tumor in a subject. The methods include administering to a subject a therapeutically effective amount of a dominant negative tumor...
10543263 Compositions and methods for treating cancer with anti-CD22 immunotherapy  
Chimeric antigen receptors (CARs) containing CD22 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical...
10543233 Drug resistant immunotherapy for treatment of a cancer  
The present disclosure is generally related to methods for combining chemotherapy and immunotherapy for the treatment of a cancer. The methods also relate to generating a drug-resistant cytotoxic...
10543231 Methods and materials for treating cancer  
This document provides methods and materials involved in treating cancer. For example, methods and materials involved in making and using particles (e.g., gold nanoparticles) containing a...
10543189 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer  
The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds,...
10540570 Predicting prostate cancer recurrence in pre-treatment prostate magnetic resonance imaging (MRI) with combined tumor induced organ distension and tumor radiomics  
Embodiments predict prostate cancer (PCa) biochemical recurrence (BCR) employing an image acquisition circuit that accesses a first pre-treatment image and a second pre-treatment image of a region...
10539576 Lung cancer differential marker  
An object of the present invention is to develop and provide a lung cancer differential marker with which lung cancer can be diagnosed conveniently and highly sensitively without depending only on...
10539566 Use of markers including filamin A in the diagnosis and treatment of prostate cancer  
Methods for diagnosing the presence of prostate cancer in a subject are provided, such methods including the detection of levels of variety of biomarkers diagnostic of prostate cancer, including...
10539565 Methods for determining prognosis of colorectal cancer  
Provided herein are methods for determining the risk that a subject diagnosed with colorectal cancer will develop a recurrence of colorectal cancer and methods of predicting clinical outcome for a...
10538817 Method for diagnosing and treating ovarian cancer  
Provided are a composition, a kit, and a method of predicting prognosis of ovarian cancer or a risk of recurrence of ovarian cancer. Provided are a composition for treating ovarian cancer or...
10538742 Methods and means related to cancer stem cells  
This invention relates to the methods for the identification and isolation of cancer stem cells from cultured cancer cell lines. Cell line-derived cancer stem cells isolated using the present...
10538739 Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease  
The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance...
10538566 Fusion proteins for treating cancer and related methods  
Aspects of the disclosure provide fusion proteins that bind cells expressing one or more target molecules including, for example, one or more cell surface multisubunit signaling receptors (e.g.,...
10538544 Method for administering cisplatin and a thiocyanate complex to treat ovarian cancer  
The invention is directed to platinum(II) complexes comprising dithiocarbamates and methods for treating cancer using these complexes.
10537636 Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant  
The present document describes a method of inhibiting cancer tumor growth in a patient in need thereof, comprising at least a first treatment comprising steps a) and b): a) administering to the...
10537626 HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell  
The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 15 and consisting of 11 or less amino acid residues.
10537625 Micro-RNA-155 enhances the efficacy of dendritic cell vaccine for cancer  
Engineered dendritic cell vaccines, and methods of forming and applying same, that may be used as effective immunotherapies for cancers.
10537611 Methods of treating lung cancer  
Methods of treating cancers comprising FGFR1 gene amplification are provided. In some embodiments, the methods comprise administering a fibroblast growth factor receptor 1 (FGFR1) extracellular...
10537610 Peptide for inhibition of cancer  
Methods for treating breast cancer, the methods can include administering to a subject an effective amount of a cell adhesion molecule Receptor (F11R peptide).